» Articles » PMID: 18084622

Expression of Androgen Receptor is Negatively Regulated by P53

Overview
Journal Neoplasia
Publisher Elsevier
Specialty Oncology
Date 2007 Dec 18
PMID 18084622
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Increased expression of androgen receptor (AR) in prostate cancer (PC) is associated with transition to androgen independence. Because the progression of PC to advanced stages is often associated with the loss of p53 function, we tested whether the p53 could regulate the expression of AR gene. Here we report that p53 negatively regulates the expression of AR in prostate epithelial cells (PrECs). We found that in LNCaP human prostate cancer cells that express the wild-type p53 and AR and in human normal PrECs, the activation of p53 by genotoxic stress or by inhibition of p53 nuclear export downregulated the expression of AR. Furthermore, forced expression of p53 in LNCaP cells decreased the expression of AR. Conversely, knockdown of p53 expression in LNCaP cells increased the AR expression. Consistent with the negative regulation of AR expression by p53, the p53-null HCT116 cells expressed higher levels of AR compared with the isogenic HCT116 cells that express the wildtype p53. Moreover, we noted that in etoposide treated LNCaP cells p53 bound to the promoter region of the AR gene, which contains a potential p53 DNA-binding consensus sequence, in chromatin immunoprecipitation assays. Together, our observations provide support for the idea that the loss of p53 function in prostate cancer cells contributes to increased expression of AR.

Citing Articles

Sex Disparities in P53 Regulation and Functions: Novel Insights for Personalized Cancer Therapies.

Cardano M, Buscemi G, Zannini L Cells. 2025; 14(5).

PMID: 40072091 PMC: 11898824. DOI: 10.3390/cells14050363.


METTL3-mediated mA modification of circGLIS3 promotes prostate cancer progression and represents a potential target for ARSI therapy.

Cheng X, Yang H, Chen Y, Zeng Z, Liu Y, Zhou X Cell Mol Biol Lett. 2024; 29(1):109.

PMID: 39143552 PMC: 11325714. DOI: 10.1186/s11658-024-00628-z.


Hair Thickness Growth Effect of Adenosine Complex in Male-/Female-Patterned Hair Loss via Inhibition of Androgen Receptor Signaling.

Kim J, Shin J, Choi Y, Joo J, Kwack M, Sung Y Int J Mol Sci. 2024; 25(12).

PMID: 38928239 PMC: 11204140. DOI: 10.3390/ijms25126534.


AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.

Tahsin S, Sane N, Cernyar B, Jiang L, Zohar Y, Lee B Oncogene. 2024; 43(27):2092-2103.

PMID: 38769192 PMC: 11702291. DOI: 10.1038/s41388-024-03064-7.


Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment.

Melnik B Cells. 2023; 12(22).

PMID: 37998335 PMC: 10670572. DOI: 10.3390/cells12222600.


References
1.
Alimirah F, Chen J, Xin H, Choubey D . Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 protein. FEBS Lett. 2006; 580(6):1659-64. DOI: 10.1016/j.febslet.2006.02.015. View

2.
Sun C, Shi Y, Xu L, Nageswararao C, Davis L, Segawa T . Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival. Oncogene. 2006; 25(28):3905-13. DOI: 10.1038/sj.onc.1209424. View

3.
Wu Y, Mehew J, Heckman C, Arcinas M, Boxer L . Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene. 2001; 20(2):240-51. DOI: 10.1038/sj.onc.1204067. View

4.
Chesire D, Isaacs W . Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor. Oncogene. 2002; 21(55):8453-69. DOI: 10.1038/sj.onc.1206049. View

5.
Oren M, Rotter V . Introduction: p53--the first twenty years. Cell Mol Life Sci. 1999; 55(1):9-11. PMC: 11146882. DOI: 10.1007/s000180050265. View